VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved therapeutic assets, today announced a ...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--#ai--VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved ...

Tainan, Taiwan, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing innovative ...

Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies The CHAI platform extracted quantitative histomorphologic features from whole-slide images of ...

YARMOUTH, Maine – The current advance beneficiary form of noncoverage, ABN Form CMS-R-131, is scheduled to expire on Jan. 31, 2026, according to an update posted by Noridian Healthcare Solutions, the ...

Singapore’s Defence Science and Technology Agency (DSTA) and the Republic of Korea’s Korean Register (KR) have signed a Memorandum of Understanding (MOU) to co-develop a framework to strengthen ...

Abstract: By seamlessly merging virtual simulations with actual driving data, the test framework for Advanced Driver Assistance Systems (ADAS) developed in this research intends to greatly enhance ...